Back
Halozyme Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
HALO
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Buy
69
HALO
Halozyme Therapeutics
Last Price:
60.65
Seasonality Move:
16.49%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeHalozyme Therapeutics Price Quote
$60.65
+1.93 (+3.29%)
(Updated: November 6, 2024 at 4:20 PM ET)
Halozyme Therapeutics Key Stats
Buy
69
Halozyme Therapeutics (HALO)
is a Buy
Day range:
$57.09 - $58.74
52-week range:
$33.15 - $65.53
Dividend yield:
0%
P/E ratio:
27.96
P/S ratio:
8.05
P/B ratio:
16.5%
Volume:
1.1M
Avg. volume:
1.4M
1-year change:
65.04%
Market cap:
$7.5B
Revenue:
$829.3M
EPS:
$3.02
How Much Does Halozyme Therapeutics Make?
-
How Much Are Halozyme Therapeutics's Sales Annually?
HALO Revenues are $829.3M -
How Much Profit Does Halozyme Therapeutics's Make A Year?
HALO net income is $281.6M
Is Halozyme Therapeutics Growing As A Company?
-
What Is Halozyme Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.34% -
What Is Halozyme Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0.72%
Halozyme Therapeutics Stock Price Performance
-
Did Halozyme Therapeutics Stock Go Up Last Month?
Halozyme Therapeutics share price went down by -0.78% last month -
Did HALO's Share Price Rise Over The Last Year?
HALO share price rose by 65.04% over the past 1 year
What Is Halozyme Therapeutics 52-Week High & Low?
-
What Is Halozyme Therapeutics’s 52-Week High Share Price?
Halozyme Therapeutics has traded as high as $65.53 over the past 52 weeks -
What Is Halozyme Therapeutics’s 52-Week Low Share Price?
Halozyme Therapeutics has traded as low as $33.15 over the past 52 weeks
Halozyme Therapeutics Price To Free Cash Flow
-
Is Halozyme Therapeutics Stock Overvalued?
Halozyme Therapeutics is trading at a price to free cash flow ratio of 19.41 -
Is Halozyme Therapeutics Stock Undervalued?
Halozyme Therapeutics EV to Free Cash Flow ratio is 21.16 -
What Is Halozyme Therapeutics’s Price Earnings Growth Ratio?
HALO PEG ratio is 0.32 -
Is Halozyme Therapeutics Trading At A Premium To Earnings?
Halozyme Therapeutics EV to EBIT ratio is 16.65
Is It Risky To Buy Halozyme Therapeutics?
-
How Much Debt Does Halozyme Therapeutics Have?
Total long term debt quarterly is $1.5B -
How Much Cash Does Halozyme Therapeutics Have?
Cash and short term investments quarterly total is $666.3M -
What Is Halozyme Therapeutics’s Book Value Per Share?
Book value per share is 3.56
Is Halozyme Therapeutics Cash Flow Positive?
-
What Is HALO Cash Flow From Operations?
Cash flow from operations (TTM) is $403M -
What Is Halozyme Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$222.4M -
What Is Halozyme Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$300.5M
Halozyme Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
HALO return on invested capital is 22.41% -
What Is Halozyme Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is 20.54% -
What Is HALO Return On Equity?
ROE is a measure of profitability and is 156.62%
Halozyme Therapeutics Earnings Date & Stock Price
-
What Is Halozyme Therapeutics's Stock Price Today?
A single share of HALO can be purchased today for 58.72 -
What Is Halozyme Therapeutics’s Stock Symbol?
Halozyme Therapeutics trades on the nasdaq under the ticker symbol: HALO -
When Is Halozyme Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Halozyme Therapeutics is scheduled on February 20, 2025 -
When Is HALO's next ex-dividend date?
Halozyme Therapeutics's next ex-dividend date is November 6, 2024 -
How To Buy Halozyme Therapeutics Stock?
You can buy Halozyme Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Halozyme Therapeutics Competitors
-
Who Are Halozyme Therapeutics's Competitors?
Below is a list of companies who compete with Halozyme Therapeutics or are related in some way:
Halozyme Therapeutics Dividend Yield
-
What Is HALO Dividend Yield?
Halozyme Therapeutics’s dividend yield currently is 0% -
What Is Halozyme Therapeutics’s Payout Ratio?
Halozyme Therapeutics’s payout ratio is 0% -
When Did Halozyme Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 6, 2024 -
What Is Halozyme Therapeutics’s Dividend Per Share?
Halozyme Therapeutics pays a dividend of $0.00 per share
Halozyme Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 72.13% | 27.05% |
Revenue: | 34.28% | 15.04% |
Analyst Recommendations
Buy Recommendations: | 3 |
---|---|
Hold Recommendations: | 5 |
Sell Recommendations: | 0 |
Price Target: | 62.60 |
Upside from Last Price: | 6.61% |